Platelet activating factor

Platelet activating factor is a lipid of Glycerophospholipids (GP) class. Platelet activating factor is associated with abnormalities such as Atherosclerosis, Acute cholecystitis without calculus, Cholecystitis, Colitis and Cholecystitis, Acute. The involved functions are known as Cell Survival, Metabolic Inhibition, lipid oxidation, Apoptosis and Oxidation. Platelet activating factor often locates in soluble, Cellular Membrane, Smooth muscle (tissue), Intima and Tissue specimen. The associated genes with Platelet activating factor are apolipoprotein A-I Milano, Homologous Gene, TSPO gene, HBEGF gene and SLC33A1 gene. The related lipids are Hydroxycholesterols, Liposomes, 25-hydroxycholesterol, Lysophosphatidylcholines and Lipopolysaccharides. The related experimental models are Knock-out, Mouse Model and Transgenic Model.

Cross Reference

Introduction

To understand associated biological information of Platelet activating factor, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Platelet activating factor?

Platelet activating factor is suspected in Ischemia, Pleurisy, Atherosclerosis, Inflammatory disorder, Retinal Diseases, Diabetes and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Platelet activating factor

MeSH term MeSH ID Detail
Asphyxia Neonatorum D001238 4 associated lipids
Asthma D001249 52 associated lipids
Pulmonary Atelectasis D001261 1 associated lipids
Behcet Syndrome D001528 7 associated lipids
Birth Weight D001724 23 associated lipids
Blister D001768 16 associated lipids
Blood Platelet Disorders D001791 12 associated lipids
Body Weight D001835 333 associated lipids
Bovine Virus Diarrhea-Mucosal Disease D001912 2 associated lipids
Brain Diseases D001927 27 associated lipids
Per page 10 20 50 100 | Total 288

PubChem Associated disorders and diseases

What pathways are associated with Platelet activating factor

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Platelet activating factor?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Platelet activating factor?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Platelet activating factor?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with Platelet activating factor?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Platelet activating factor?

Knock-out

Knock-out are used in the study 'A cardioprotective role for platelet-activating factor through NOS-dependent S-nitrosylation.' (Leary PJ et al., 2008).

Mouse Model

Mouse Model are used in the study 'A regulatory role of LPCAT1 in the synthesis of inflammatory lipids, PAF and LPC, in the retina of diabetic mice.' (Cheng L et al., 2009).

Transgenic Model

Transgenic Model are used in the study 'Heterogeneity in the sn-1 carbon chain of platelet-activating factor glycerophospholipids determines pro- or anti-apoptotic signaling in primary neurons.' (Ryan SD et al., 2008).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with Platelet activating factor

Download all related citations
Per page 10 20 50 100 | Total 8526
Authors Title Published Journal PubMed Link
Lagente V et al. Interference of the PAF-acether antagonist BN 52021 with passive anaphylaxis in the guinea-pig. 1987 Prostaglandins pmid:2438723
Mike I et al. The differences in 12-hydroxyeicosatetraenoic acid and thromboxane B2 release from guinea pig platelets. 1991 Prostaglandins pmid:1763200
Wallace JL and Whittle BJ Picomole doses of platelet-activating factor predispose the gastric mucosa to damage by topical irritants. 1986 Prostaglandins pmid:3726156
Rossi AG and O'Flaherty JT Prostaglandin binding sites in human polymorphonuclear neutrophils. 1989 Prostaglandins pmid:2549574
Montrucchio G et al. In vitro contractile effect of platelet-activating factor on guinea-pig myometrium. 1986 Prostaglandins pmid:3797692
McCulloch RK and Vandongen R Mechanisms of platelet activating factor-induced aggregation and secretion in human platelets. 1990 Prostaglandins pmid:2106712
Silver RK et al. Acetylsalicylic acid inhibits anticardiolipin antibody-induced platelet-activating factor (PAF) synthesis. 1993 Prostaglandins pmid:8430224
Billah MM et al. Platelet-activating factor metabolism in human amnion and the responses of this tissue to extracellular platelet-activating factor. 1985 Prostaglandins pmid:3936121
Acker G et al. Role of platelet-activating factor (PAF) in the ovoimplantation in the rat: effect of the specific PAF-acether antagonist, BN 52021. 1988 Prostaglandins pmid:3129758
Toyofuku T et al. Effects of ONO-6240, a platelet-activating factor antagonist, on endotoxin shock in unanesthetized sheep. 1986 Prostaglandins pmid:3754344
Stratton MD et al. The effect of Clostridium difficile toxin on colonocyte prostanoid activity. 1994 Prostaglandins pmid:7892508
Bussolino F and Camussi G Effect of prostacyclin on platelet-activating factor induced rabbit and platelet aggregation. 1980 Prostaglandins pmid:6258196
Silver RK et al. Amniotic fluid platelet-activating factor (PAF) is elevated in patients with tocolytic failure and preterm delivery. 1992 Prostaglandins pmid:1542743
Cucala M et al. Central regulation of gastric acid secretion by platelet-activating factor in anesthesized rats. 1989 Prostaglandins pmid:2499013
Adnot S et al. Interference of the PAF-acether antagonist BN 52021 with endotoxin-induced hypotension in the guinea-pig. 1986 Prostaglandins pmid:3562865
Levine L Actions of vanadate on arachidonic acid metabolism by cells in culture. 1991 Prostaglandins pmid:2020748
Bourgain RH et al. The effect of 1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine (paf-acether) on the arterial wall. 1985 Prostaglandins pmid:3931178
Kuzan FB et al. Role of spermatozoal platelet-activating factor in fertilization. 1990 Prostaglandins pmid:2155438
Boughton-Smith NK et al. Relationship between PAF-acether and thromboxane A2 biosynthesis in endotoxin-induced intestinal damage in the rat. 1989 Prostaglandins pmid:2506613
Levine L Effects of okadaic acid on agonist-stimulated PGI2 production by rat liver cells (the C-9 cell line). 1991 Prostaglandins pmid:1647047
Dembinska-Kiec A et al. The effects of platelet-activating factor on flow rate and eicosanoid release in the isolated perfused rat gastric vascular bed. 1989 Prostaglandins pmid:2717778
Takehara S et al. Pharmacological actions of Y-24180, a new specific antagonist of platelet activating factor (PAF): II. Interactions with PAF and benzodiazepine receptors. 1990 Prostaglandins pmid:1965554
Kaminski DL et al. Studies on the etiology of acute acalculous cholecystitis: the effect of lipopolysaccharide on human gallbladder mucosal cells. 1994 Prostaglandins pmid:8041874
Jancar S et al. Comparative effects of platelet activating factor, leukotriene D4 and histamine on guinea pig trachea, bronchus and lung parenchyma. 1987 Prostaglandins pmid:3588970
Malo PE et al. Enhancement of leukotriene D4-induced contraction of guinea-pig isolated trachea by platelet activating factor. 1987 Prostaglandins pmid:3588971
Kim CJ et al. Eosinophils recruited to the lung by segmental antigen challenge show a reduced chemotactic response to leukotriene B4. 1994 Prostaglandins pmid:8066187
Madden MC et al. Polarized release of lipid mediators derived from phospholipase A2 activity in a human bronchial cell line. 1994 Prostaglandins pmid:7809385
Bruijnzeel PL et al. Platelet-activating factor induces leukotriene C4 synthesis by purified human eosinophils. 1987 Prostaglandins pmid:3118415
Pons L et al. Role of platelet-activating factor (PAF) and prostaglandins in colonic motor and secretory disturbances induced by Escherichia coli endotoxin in conscious rats. 1994 Prostaglandins pmid:8016383
Lee MJ et al. Endothelial cell 1-acyl-platelet-activating factor synthesis in response to anticardiolipin antibody-positive serum fractions. 1994 Prostaglandins pmid:8016391
Kaminski DL et al. The production of experimental cholecystitis by endotoxin. 1994 Prostaglandins pmid:8016392
Ibbotson GC and Wallace JL Beneficial effects of prostaglandin E2 in endotoxic shock are unrelated to effects on PAF-acether synthesis. 1989 Prostaglandins pmid:2727308
Yamanaka S et al. 11-Dehydro thromboxane B2: a reliable parameter of thromboxane A2 production in dogs. 1993 Prostaglandins pmid:8484010
Goldenberg MM and Meurer RD A pharmacologic analysis of the action of platelet-activating factor in the induction of hindpaw edema in the rat. 1984 Prostaglandins pmid:6505225
Myers AK et al. Antagonism of PAF-induced death in mice. 1988 Prostaglandins pmid:3131837
Levine L Effects of the protein kinase inhibitors, staurosporine and K-252a, on PGI2 production by rat liver cells (the C-9 cell line). 1990 Prostaglandins pmid:2247616
Whatley RE et al. Relative amounts of 1-O-alkyl- and 1-acyl-2-acetyl-sn-glycero-3-phosphocholine in stimulated endothelial cells. 1992 Prostaglandins pmid:1546171
Satoh K et al. Activity of platelet-activating factor (PAF) acetylhydrolase in plasma from patients with ischemic cerebrovascular disease. 1988 Prostaglandins pmid:3399678
There is a case for PAF-acether antagonists. Abstracts of the conference. Paris, France, May 25-27, 1988. 1988 Prostaglandins pmid:3399682
Subissi A et al. Effects of anti-asthma drugs on PAF-induced death in mice. 1988 Prostaglandins pmid:2907663
Jager GV et al. Antagonist of platelet-activating factor prevents prostaglandin E2 induced ocular hypertension in rabbits. 1993 Prostaglandins pmid:8424134
Radeau T et al. Enhanced esterification process of 5-hydroxyeicosatetraenoic acid (5-HETE) in PMN from asthmatic patients. 1992 Prostaglandins pmid:1410523
Orevi M et al. A potent inhibitor of platelet activating factor from the saliva of the leech Hirudo medicinalis. 1992 Prostaglandins pmid:1584997
Qu X et al. Endotoxin induces PAF production in the rat ileum: quantitation of tissue PAF by an improved method. 1996 Prostaglandins pmid:8935185
Etienne A et al. Modulation of eosinophil recruitment in the rat by the platelet-activating factor (PAF) antagonist, BN 52021, the somatostatin analog, BIM 23014, and by cyclosporin A. 1989 Prostaglandins pmid:2748916
Yue TL et al. Pharmacologic profile of BN 50739, a new PAF antagonist in vitro and in vivo. 1990 Prostaglandins pmid:2353116
Terasawa M et al. Pharmacological actions of Y-24180: I. A potent and specific antagonist of platelet-activating factor. 1990 Prostaglandins pmid:2093935
Cirino M et al. A study with BN 52021 demonstrates the involvement of PAF-acether in IgE-dependent anaphylactic bronchoconstriction. 1986 Prostaglandins pmid:3763941
Wallace JL and Whittle BJ Profile of gastrointestinal damage induced by platelet-activating factor. 1986 Prostaglandins pmid:3763942
Bourgain RH et al. Thrombus induction by endogenic paf-acether and its inhibition by Ginkgo Biloba extracts in the guinea pig. 1986 Prostaglandins pmid:3763943
Guinot P et al. Inhibition of PAF-acether induced weal and flare reaction in man by a specific PAF antagonist. 1986 Prostaglandins pmid:3763944
Jancar S et al. Immune complex induced pancreatitis: effect of BN 52021, a selective antagonist of platelet-activating factor. 1988 Prostaglandins pmid:2969600
Pignol B et al. Effect of platelet-activating factor (PAF-acether) and its specific receptor antagonist, BN 52021, on interleukin 1 (IL1) release and synthesis by rat spleen adherent monocytes. 1987 Prostaglandins pmid:3313526
Braquet P and Rola-Pleszczynski M The role of PAF in immunological responses: a review. 1987 Prostaglandins pmid:3313527
Young JM et al. Pharmacological investigation of the mechanisms of platelet-activating factor induced mortality in the mouse. 1985 Prostaglandins pmid:4081060
Is there a case for PAF-acether antagonists? Institut Pasteur, Paris, 21 June 1985. Abstracts. 1985 Prostaglandins pmid:4081064
Kim YD et al. Constriction of canine coronary arteries by platelet activating factor after brief ischemia. 1993 Prostaglandins pmid:8234834
Slama H et al. Metabolism of arachidonic acid by caruncular and allantochorionic tissues in cows with retained fetal membranes (RFM). 1993 Prostaglandins pmid:8380936
Turner-Gomes SO et al. Effect of ambient oxygen changes on platelet activating factor production by fetal ovine endothelial cells. 1991 Prostaglandins pmid:1862226
Ashida Y et al. A novel anti-asthmatic quinone derivative, AA-2414 with a potent antagonistic activity against a variety of spasmogenic prostanoids. 1989 Prostaglandins pmid:2748922
Myers SI et al. Platelet activating factor (PAF) stimulates release of PGI2 from inflamed rabbit gallbladder cell cultures. 1995 Prostaglandins pmid:8588069
Spinnewyn B et al. Involvement of platelet-activating factor (PAF) in cerebral post-ischemic phase in Mongolian gerbils. 1987 Prostaglandins pmid:3432553
Guinot P et al. Effect of BN 52063, a specific PAF-acether antagonist, on bronchial provocation test to allergens in asthmatic patients. A preliminary study. 1987 Prostaglandins pmid:3432562
Armstrong RA et al. Mechanism of the inhibition of platelet aggregation produced by prostaglandin F2 alpha. 1985 Prostaglandins pmid:2988022
Ernst A et al. The effect of PAF in the cochlea of guinea pigs. 1989 Prostaglandins pmid:2602560
Archer CB et al. Synergistic interaction between prostaglandins and PAF-acether in experimental animals and man. 1984 Prostaglandins pmid:6203139
Chan WP and Levy JV Effects of antiplatelet agents on platelet aggregation induced by platelet--activating factor (PAF) in human whole blood. 1991 Prostaglandins pmid:1665568
Kioumis I et al. Effect of inhaled platelet-activating factor on circulating neutrophils and platelets in vivo and ex vivo in man. 1988 Prostaglandins pmid:3237997
Sirois MG et al. PAF increases vascular permeability in selected tissues: effect of BN-52021 and L-655,240. 1988 Prostaglandins pmid:3238010
Sakuma Y et al. Pharmacological effects of oral E6123, a novel PAF antagonist, on biological changes induced by PAF inhalation in guinea pigs. 1991 Prostaglandins pmid:1763202
Voelkel NF et al. PAF antagonists: different effects on platelets, neutrophils, guinea pig ileum and PAF-induced vasodilation in isolated rat lung. 1986 Prostaglandins pmid:3024235
Camussi G et al. Inhibitory effect of prostacyclin (PGI2) on neutropenia induced by intravenous injection of platelet-activating-factor (PAF) in the rabbit. 1983 Prostaglandins pmid:6346397
Braquet M et al. Leukocytic functions in burn-injured patients. 1985 Prostaglandins pmid:2989978
Bureau M et al. Desensitization and antagonism of rat polymorphonuclear leukocytes stimulated with PAF acether. 1987 Prostaglandins pmid:3035615
Küster LJ and Frölich JC Platelet aggregation and thromboxane release induced by arachidonic acid, collagen, ADP and platelet-activating factor following low dose acetylsalicylic acid in man. 1986 Prostaglandins pmid:3097760
Bonnet J et al. Dependency of the Paf-acether induced bronchospasm on the lipoxygenase pathway in the guinea-pig. 1983 Prostaglandins pmid:6419289
Geissler FT et al. Lipid mediator production by post-implantation rat embryos in vitro. 1989 Prostaglandins pmid:2505333
Fernandes AJ et al. Mechanisms of thrombocytopenia in the acute phase of antigen-induced arthritis in rabbits. 1991 Prostaglandins pmid:1801060
White HL and Faison LD Inhibition of lyso-PAF: acetyl-CoA acetyltransferase by salicylates and other compounds. 1988 Prostaglandins pmid:2903520
Ezra D et al. Cardiac and coronary consequences of intracoronary platelet activating factor infusion in the domestic pig. 1987 Prostaglandins pmid:3685397
Grassi S and Pettorossi VE Synaptic plasticity in the medial vestibular nuclei: role of glutamate receptors and retrograde messengers in rat brainstem slices. 2001 Prog. Neurobiol. pmid:11311461
Maclennan KM et al. Platelet-activating factor in the CNS. 1996 Prog. Neurobiol. pmid:9015828
Ishii S and Shimizu T Platelet-activating factor (PAF) receptor and genetically engineered PAF receptor mutant mice. 2000 Prog. Lipid Res. pmid:10729607
Whatley RE et al. Lipid metabolism and signal transduction in endothelial cells. 1990 Prog. Lipid Res. pmid:2128404
Itabe H Oxidized phospholipids as a new landmark in atherosclerosis. 1998 Jul-Aug Prog. Lipid Res. pmid:9829125
Frisardi V et al. Glycerophospholipids and glycerophospholipid-derived lipid mediators: a complex meshwork in Alzheimer's disease pathology. 2011 Prog. Lipid Res. pmid:21703303
Hikiji H et al. The roles of prostanoids, leukotrienes, and platelet-activating factor in bone metabolism and disease. 2008 Prog. Lipid Res. pmid:18187046
Frenkel RA et al. The biochemical role of platelet-activating factor in reproduction. 1996 Prog. Lipid Res. pmid:8944225
Snyder F et al. The role of transacylases in the metabolism of arachidonate and platelet activating factor. 1992 Prog. Lipid Res. pmid:1641397
Tokumura A A family of phospholipid autacoids: occurrence, metabolism and bioactions. 1995 Prog. Lipid Res. pmid:7480064
Lagarde M Metabolism of fatty acids by platelets and the functions of various metabolites in mediating platelet function. 1988 Prog. Lipid Res. pmid:3060881
Hanahan DJ and Kumar R Platelet activating factor; chemical and biochemical characteristics. 1987 Prog. Lipid Res. pmid:3313430
Foegh ML et al. Fatty acids and eicosanoids in organ transplantation. 1986 Prog. Lipid Res. pmid:3321095
Touvay C et al. Proof of the involvement of platelet activating factor (paf-acether) in pulmonary complex immune systems using a specific paf-acether receptor antagonist: BN 52021. 1986 Prog. Lipid Res. pmid:2827186
Damiani E and Ullrich SE Understanding the connection between platelet-activating factor, a UV-induced lipid mediator of inflammation, immune suppression and skin cancer. 2016 Prog. Lipid Res. pmid:27073146
Stjernschantz J and Bito LZ The ocular effects of eicosanoids and other autacoids: historic background and the need for a broader perspective. 1989 Prog. Clin. Biol. Res. pmid:2571999
Valone FH et al. Mechanisms for biphasic or persistent immunologic reactions induced by platelet-activating factor. 1989 Prog. Clin. Biol. Res. pmid:2685826
Harper MJ et al. Platelet-activating factor (PAF) and blastocyst-endometrial interactions. 1989 Prog. Clin. Biol. Res. pmid:2542988
Benveniste J Paf-acether, an ether phospho-lipid with biological activity. 1988 Prog. Clin. Biol. Res. pmid:3071808
Dulioust A et al. Immunoregulatory functions of paf-acether (platelet-activating factor). 1988 Prog. Clin. Biol. Res. pmid:3071809